Tech Company Financing Transactions
SynCardia Systems Funding Round
SynCardia Systems secured a $19 million funding round on 3/20/2013. Investors included Athyrium Opportunities Fund and private investors.
Transaction Overview
Company Name
Announced On
3/20/2013
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$19,000,000
Round
Undisclosed
Investors
Athyrium Opportunities Fund (Laurent Hermouet)
Proceeds Purpose
The proceeds will help support commercialization of our Freedom portable driver, the world's first wearable power supply for the SynCardia temporary Total Artificial Heart, and accelerate the launch of our new, smaller 50cc Total Artificial Heart.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
1992 East Silverlake Road
Tucson, AZ 85713
USA
Tucson, AZ 85713
USA
Phone
Website
Email Address
Overview
SynCardia Systems, Inc. is the manufacturer of the CardioWest temporary Total Artificial Heart (TAH-t). It is the only FDA and CE approved temporary Total Artificial Heart in the world. It is designed for severely ill patients with end-stage biventricular failure.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Garippa
Chief Financial Officer
Dan Hudspeth
Chief Operating Officer
Douglas Nutter
Browse more venture capital transactions:
Prev: 3/20/2013: Concurrent venture capital transaction
Next: 3/20/2013: ScoreBig venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs